Our Enduring Purpose
To fundamentally improve the lives of patients with serious diseases in ways never before possible.
Our Platform
Our powerful IND engine – comprised of our protein library, differentiated screening technologies and protein therapeutic generation capabilities – is unmatched.
Our Pipeline
Our robust pipeline of novel protein therapeutics is expanding while simultaneously progressing into late-stage development.
Our Culture
We focus on scientific innovation, embracing our entrepreneurial spirit and encouraging teamwork.
Recent News
SEPTEMBER 26, 2018
Five Prime Therapeutics to Present at Leerink Partners Roundtable Series: Rare Disease & Oncology
